SPR Therapeutics Competitors, Revenue, Alternatives and Pricing
Overview
Industry Ranking
Estimated Revenue & Financials
- SPR Therapeutics's estimated annual revenue is currently $15.6M per year.
- SPR Therapeutics received $25.0M in venture funding in September 2017.
- SPR Therapeutics's estimated revenue per employee is $251,000
- SPR Therapeutics's total funding is $50.5M.
Employee Data
- SPR Therapeutics has 62 Employees.
- SPR Therapeutics grew their employee count by 35% last year.
- SPR Therapeutics currently has 1 job openings.
SPR Therapeutics Competitors
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
|---|---|---|---|---|---|---|
| Advertise Here | ||||||
#1 | $243.2M | 969 | N/A | N/A | - | N/A |
#2 | $32.6M | 130 | 7% | N/A | - | N/A |
#3 | $118.2M | 471 | N/A | N/A | - | N/A |
#4 | $368M | 1466 | N/A | N/A | 4.2/5 | N/A |
#5 | $33.6M | 134 | N/A | N/A | - | N/A |
#6 | $95.9M | 382 | N/A | N/A | - | N/A |
#7 | $9.8M | 39 | 18% | N/A | - | N/A |
#8 | $6.3M | 25 | N/A | N/A | - | N/A |
#9 | $11.3M | 45 | N/A | N/A | - | N/A |
#10 | $11.3M | 45 | N/A | N/A | - | N/A |
What Is SPR Therapeutics?
SPR Therapeutics is committed to improving the lives of millions of pain sufferers with its peripheral nerve stimulation (PNS) platform technology poised to be the standard of care and ultimately, the treatment of choice for pain management. Led by a world-class team of scientists, physicians, and business professionals with a track record of commercializing innovative neurostimulation products, SPR's PNS therapy for acute and chronic pain management provides a non-narcotic, reversible, safe, effective and more affordable alternative to addictive opioid medications and invasive surgeries.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals62
Number of Employees
$15.6M
Revenue (est)
1
Current Jobs
35%
Employee Growth %
$50.5M
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
SPR Therapeutics News
SPR Therapeutics' SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim ...
Medtronic; LABORIE; Stimwave LLC; SunMed; Vygon SA; Medline Industries, Inc.; NeuroMetrix, Inc.; SPR Therapeutics; NeuroSigma, Inc.; ...
SPR Therapeutics, developer of a peripheral nerve stimulation therapy platform designed to be an alternative to addictive opioid medications, ...
SPR Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2011-04-27 | $0.2M | Undisclosed | JumpStart Ventures | Article |
| 2012-01-25 | $2.2M | A | NDI Medical | Article |
| 2013-01-09 | $5.0M | A | NDI Healthcare Fund, Public Square Partners | Article |
| 2014-06-12 | $3.9M | Undisclosed | Article | |
| 2017-09-13 | $25.0M | C | Article |
SPR Therapeutics Executive Hires
| Date | Name | Title | Reference |
|---|---|---|---|
| 2017-01-19 | Dave Youngberg | Vice President Sales | Article |
| 2017-09-08 | Joseph Boggs | SVP Research/Development | Article |